Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 104
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Pharmazie ; 77(2): 85-88, 2022 02 01.
Artigo em Inglês | MEDLINE | ID: mdl-35209969

RESUMO

The use of cisplatin may cause nephrotoxicity in patients. Hydration solutions supplemented with magnesium could reduce cisplatin-induced nephrotoxicity. In this study, we evaluated the preventive effect of magnesium pre-loading on cisplatin-induced nephrotoxicity in patients with esophageal cancer. We retrospectively evaluated the prevalence of, and risk factors for, nephrotoxicity in 160 patients with esophageal cancer treated with the 5-fluorouracil/cisplatin regimen from 2014 to 2016 with and without magnesium supplementation. Significant differences were observed between the magnesium and non-magnesium groups in terms of frequency of estimated creatinine clearance of grade 2 or higher that was at 4% (n = 3) and 13% (n = 10) (p = 0.027), respectively. The logistic regression analysis revealed that eCcr of grade 2 or higher was significantly associated with the non-magnesium regimen (odds ratio (OR), 4.175; 95% confidence interval (CI) = 1.061-16.430; p = 0.041) and age ≥ 65 years (OR, 13.951; 95% CI = 1.723-112.974; p = 0.014). This study suggests that 20 mEq magnesium pre-loading significantly reduces the prevalence of cisplatin-induced nephrotoxicity. Furthermore, when cisplatin is administered to individuals older than 64 years, a close observation for the onset of cisplatin-induced nephrotoxicity is crucial.


Assuntos
Antineoplásicos , Neoplasias Esofágicas , Nefropatias , Idoso , Antineoplásicos/efeitos adversos , Cisplatino/efeitos adversos , Neoplasias Esofágicas/tratamento farmacológico , Fluoruracila/efeitos adversos , Humanos , Nefropatias/induzido quimicamente , Magnésio/efeitos adversos , Estudos Retrospectivos
2.
Pharmacogenomics J ; 13(5): 443-51, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22711062

RESUMO

Interferon beta (IFNß) reduces disease burden in relapsing-remitting multiple sclerosis (MS) patients. In this study, IFNß-1b-treated MS patient gene expression profiles and biological knowledgebases were integrated to study IFNß's pleiotropic mechanisms of action. Genes involved in immune regulation, mitochondrial fatty acid metabolism and antioxidant activity were discovered. Plausible mediators of neuronal preservation included NRF2, downregulation of OLA1, an antioxidant suppressor, and the antioxidant gene ND6, implicated in optic neuropathy and MS-like lesions. Network analysis highlighted IKBKE, which likely has a role in both viral response and energy metabolism. A comparative analysis of therapy-naive MS- and IFNß-associated gene expression suggests an IFNß insufficiency in MS. We observed more gene expression changes in long-term treatment than during acute dosing. These distinct short- and long-term effects were driven by different transcription factors. Multi-gene biomarker signatures of IFNß treatment effects were developed and subsequently confirmed in independent IFNß-1b-treated MS studies, but not in glatiramer acetate-treated patients.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Interferon beta/uso terapêutico , Esclerose Múltipla/tratamento farmacológico , Adenosina Trifosfatases/genética , Adenosina Trifosfatases/imunologia , Adenosina Trifosfatases/metabolismo , Adulto , Antioxidantes/metabolismo , Biomarcadores Farmacológicos/metabolismo , Regulação para Baixo , Ácidos Graxos/genética , Ácidos Graxos/imunologia , Ácidos Graxos/metabolismo , Feminino , Proteínas de Ligação ao GTP/genética , Proteínas de Ligação ao GTP/imunologia , Proteínas de Ligação ao GTP/metabolismo , Humanos , Quinase I-kappa B/genética , Quinase I-kappa B/imunologia , Quinase I-kappa B/metabolismo , Interferon beta-1b , Interferon beta/imunologia , Masculino , Pessoa de Meia-Idade , Mitocôndrias/genética , Mitocôndrias/imunologia , Mitocôndrias/metabolismo , Esclerose Múltipla/genética , Esclerose Múltipla/imunologia , NADH Desidrogenase/genética , NADH Desidrogenase/imunologia , NADH Desidrogenase/metabolismo , Fator 2 Relacionado a NF-E2/genética , Fator 2 Relacionado a NF-E2/imunologia , Fator 2 Relacionado a NF-E2/metabolismo , Fatores de Transcrição/genética , Fatores de Transcrição/imunologia , Fatores de Transcrição/metabolismo , Transcriptoma
3.
Eur J Clin Nutr ; 64(2): 221-3, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19920848

RESUMO

Iron deficiency is the most common cause of anemia in pregnancy. Pregnant women with anemia are, in general, exclusively treated with iron supplementation. We observed that several pregnant women with anemia who were nonresponsive to iron supplementation also had vitamin B6 deficiency, and that anemia in these cases improved with the administration of vitamin B6. Our prospective study in healthy pregnant women showed that blood levels of iron, ferritin and vitamin B6, in particular, fell to the lower limit of the nonpregnant reference range by the third trimester. We conclude that it is important to take into account the deficiency of vitamin B6 besides iron in the evaluation of anemia during pregnancy.


Assuntos
Anemia Ferropriva/tratamento farmacológico , Ferro/uso terapêutico , Complicações na Gravidez/sangue , Gravidez/sangue , Deficiência de Vitamina B 6/tratamento farmacológico , Vitamina B 6/sangue , Complexo Vitamínico B/uso terapêutico , Adulto , Anemia Ferropriva/sangue , Feminino , Ferritinas/sangue , Humanos , Ferro/sangue , Deficiências de Ferro , Estudos Prospectivos , Valores de Referência , Vitamina B 6/uso terapêutico , Deficiência de Vitamina B 6/sangue , Complexo Vitamínico B/sangue
4.
Lupus ; 18(1): 44-52, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19074168

RESUMO

Royal jelly (RJ) is a gelatinous secretion from young nurse worker bees (Apis mellifera), which serves as the sole food for the queen bee. Because of its pleiotropic functions for queen bees, RJ has also been used as a dietary supplement with various health benefits for humans. Because RJ is being indicated to have immunomodulatory potential for humans, we undertook the study to determine whether the oral administration of RJ could alter the development of systemic autoimmunity in New Zealand Black (NZB) x New Zealand White (NZW) F1 mice that genetically exhibit many manifestations similar to human systemic lupus erythematosus (SLE). We herein reported that mice administered with RJ showed a significant delay in the onset of the disease, as manifested by decreased proteinuria and a prolongation of lifespan. In addition, RJ administration after the onset of the disease significantly improved the renal symptoms, leading to an extended lifespan. RJ administration to mice caused a significant decrease in the serum level of IL-10, and in the autoantibodies against ssDNA, dsDNA and erythrocytes, as well as a reduction in the number of splenic autoreactive B cells. In conclusion, our data suggest that the use of RJ may be beneficial in the prevention of the early onset of SLE and in the control of the active progression of the manifestations of SLE.


Assuntos
Autoanticorpos/efeitos dos fármacos , Autoimunidade/efeitos dos fármacos , Ácidos Graxos/farmacologia , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Administração Oral , Animais , Autoanticorpos/metabolismo , Abelhas , DNA/efeitos dos fármacos , DNA/metabolismo , Modelos Animais de Doenças , Eritrócitos/efeitos dos fármacos , Eritrócitos/metabolismo , Ácidos Graxos/uso terapêutico , Feminino , Interleucina-10/sangue , Longevidade/efeitos dos fármacos , Lúpus Eritematoso Sistêmico/fisiopatologia , Camundongos , Camundongos Endogâmicos NZB , Proteinúria/tratamento farmacológico , Proteinúria/etiologia
5.
Psychooncology ; 17(6): 606-11, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17972358

RESUMO

Effects of socioeconomic factors and cancer survivors' worries on their quality of life (QOL) were investigated. In 2002, Japanese national survey was performed to assess distress among cancer patients using a semi-structured questionnaire (http://www.scchr.jp/yorozu/pdf/taiken_koe_eng.pdf). We investigated relationships between patients' distress and their QOL measured by European Organization for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30) and Functional Assessment of Chronic Illness Therapy--12-item Spiritual Well-Being Scale (FACIT-Sp), using a covariance structure analysis and multivariate regression analysis. A total of 130 outpatients (male: 42%; average age: 59 years; performance status rating 0-2:89%; breast/lung/gastrointestinal cancer: 38/22/21%) answered the questionnaires. A covariance structure analysis extracted latent variables, which were named socioeconomic distress and cancer worries, using a model that sufficiently represented the observed data (Goodness of fit index = 0.833). Regression analysis demonstrated that higher family income significantly correlated with better Global health status/QOL (p = 0.003) but that losing a job negatively correlated with all of the scales on functioning in the QLQ-C30 (p < 0.05) and spiritual well-being (p < 0.05). Patients' QOL was also affected by physical worries and spiritual issues in terms of emotional, cognitive, and social functioning. In conclusion, cancer survivors' QOL was doubly affected by socioeconomic distress and cancer worries. In the former, lower family income and losing employment by experiencing cancer had a negative impact on patients' QOL. As to the latter, physical worries and spiritual issues also affected patients' QOL.


Assuntos
Ansiedade/psicologia , Neoplasias/psicologia , Qualidade de Vida/psicologia , Sobreviventes/psicologia , Atividades Cotidianas/psicologia , Adulto , Idoso , Neoplasias da Mama/psicologia , Feminino , Neoplasias Gastrointestinais/psicologia , Inquéritos Epidemiológicos , Humanos , Japão , Neoplasias Pulmonares/psicologia , Masculino , Pessoa de Meia-Idade , Inventário de Personalidade , Espiritualidade , Inquéritos e Questionários , Desemprego/psicologia
6.
Chemosphere ; 58(6): 705-14, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15621184

RESUMO

This study developed a seven-compartment model for predicting the fate of selenium (Se) in an aquatic environment containing a water-sediment boundary. Speciation of Se in water-sediment microcosms under microaerobic conditions was measured to evaluate first-order kinetics of Se transportation and transformation. The microcosm consisted of a 10-ml solution containing 1mM soluble Se as selenate (Se6+) or selenite (Se4+) and 8 g wet sediment that was free from Se contamination, sampled from the Senri, Yamato, or Yodo Rivers in Osaka, Japan. Stepwise reaction coefficients describing transportation and transformation were determined using an inverse method on this model which includes: selenate (Se(W)6+) and selenite (Se(W)4+) in ponded water; selenate (Se(S)6+) and selenite (Se(S)4+), elemental Se (Se0), organic Se (Se2-) in sediment; and gaseous Se (DMSe). During this 1-month experiment, soluble Se was transported from ponded water to the sediment and Se was transformed sequentially to other Se species through biochemical reactions. Experimental and kinetic analyses indicated quantitatively that the Yamato River microcosm, with its high organic matter content, had a high adsorption rate of soluble Se. The Yodo River microcosm had a low adsorption rate for Se6+ and a low Se reduction rate. The Senri River microcosm had an apparent high volatilization rate of DMSe. The model developed in this study is extremely useful for predicting fate of Se in aquatic environment in the field.


Assuntos
Sedimentos Geológicos , Modelos Teóricos , Selênio/metabolismo , Poluentes Químicos da Água/metabolismo , Transporte Biológico , Biotransformação , Ecossistema , Cinética , Matemática , Compostos Organosselênicos/metabolismo , Selênio/farmacocinética , Poluentes do Solo/metabolismo , Poluentes do Solo/farmacocinética , Água , Poluentes Químicos da Água/farmacocinética
7.
Eur J Cancer Prev ; 13(4): 239-48, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15554550

RESUMO

The effect of dietary fat on breast cancer is a longstanding and an unresolved issue. We found that 17beta-estradiol (E2) could be activated by the epoxide-forming oxidant dimethyldioxirane (DMDO) to bind DNA-forming DNA adducts both in vitro and in vivo, and to inhibit nuclear RNA synthesis. We proposed that E2 epoxidation is the underlying mechanism for the initiation of breast cancer carcinogenesis (Carcinogenesis 17, 1957-61, 1996). This report is on the transcriptional and DNA-binding properties of vegetable oils and fatty acids, and on the potentials of these compounds to prevent the formation of E2 epoxide. The results show that vegetable oils, having no effect on nuclear RNA synthesis either before or after DMDO treatment, were all able to prevent the formation of E2 epoxide independent of their mono- or polyunsaturated fatty acid content. Similarly, unsaturated fatty acids, regardless of chain length and number of double bonds, were all able to prevent the formation of E2 epoxide as reflected by the loss of the ability of [3H]E2 to bind DNA. In contrast to vegetable oils, the results indicated that the unsaturated fatty acids palmitoleic, oleic, linoleic, linolenic and arachidonic acid could be activated by DMDO to inhibit nuclear RNA synthesis, and that the mono-unsaturated fatty acids (i.e. palmitoleic and oleic acid) were stronger inhibitors than fatty acids with more than one double bond (e.g. linoleic, linolenic and arachidonic acid). [32P]Post-labeling analysis revealed that under identical DMDO activation, the DNA adducts formed for oleic acid were 17098 adducts/10(8) nucleotides, which was 20-fold more than palmitoleic acid (815), and 120-fold more than alpha-linolenic acid (142). This result strongly suggests that oleic acid could be a potential initiating carcinogen after epoxidation.


Assuntos
Anticarcinógenos/farmacologia , Neoplasias da Mama/prevenção & controle , Adutos de DNA/metabolismo , Ácidos Graxos Insaturados/farmacologia , Óleos de Plantas/farmacologia , Animais , Quimioprevenção/métodos , Adutos de DNA/efeitos dos fármacos , DNA Ribossômico/efeitos dos fármacos , DNA Ribossômico/metabolismo , Gorduras na Dieta/farmacologia , Estradiol/farmacologia , Feminino , Humanos , RNA Mensageiro/efeitos dos fármacos , RNA Mensageiro/metabolismo , Ratos , Sensibilidade e Especificidade , Células Tumorais Cultivadas
8.
Surg Endosc ; 18(7): 1113-7, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15136928

RESUMO

BACKGROUND: Port-site metastasis is a continuing problem in laparoscopic cancer surgery. To clarify the role of adhesion molecules in the development of port-site metastasis, particularly with regard to prevention, we performed experiments in which port-site metastasis was inhibited using antibodies against extracellular matrix proteins or the active Arg-Gly-Asp (RGD) peptide after CO2 pneumoperitoneum in a murine model. METHODS: We examined the development of port-site metastasis under the following conditions: (1) CO2 pneumoperitoneum with or without hyaluronic acid and anti-integrin or anti-CD44 antibody and (2) CO2 pneumoperitoneum and a RGD peptide or pseudo-RGD sequence peptide (FC-336). BALB/c mice ( n = 130) were injected with 5 x 10(5) human gastric cancer cells (MKN45) and either antibody or peptide, treated with CO2 pneumoperitoneum, and injected intraperitoneally with antibody or peptide for 5 days. Three weeks after CO2 pneumoperitoneum, the frequency and weight of port-site metastatic tumors were determined. RESULTS: Anti-integrin antibody significantly decreased the weight of port-site metastatic tumors without hyaluronic acid (control vs anti-integrin: 8.2 +/- 7.1 vs 3.6 +/- 4.5 mg; p < 0.05) but not the frequency of port-site metastases. With hyaluronic acid, the frequency of port-site metastasis and the weight of port-site metastatic tumors were significantly decreased both by anti-integrin and by anti-CD44 antibody (control vs anti-integrin and anti-CD44; 95% and 8.5 +/- 7.2 mg vs 50% and 3.1 +/- 4.3 mg and 55% and 3.3 +/- 5.1 mg, respectively; p < 0.05). RGD peptide and FC-336 also inhibited port-site metastasis in a dose-dependent manner. CONCLUSION: Cell adhesion molecules integrin and CD44 play an important role in the development of port-site metastasis after laparoscopic cancer surgery. Intraperitoneal injection of RGD peptide or pseudo-RGD sequence peptide (FC-336) can prevent port-site metastasis.


Assuntos
Anticorpos Monoclonais/uso terapêutico , Moléculas de Adesão Celular/fisiologia , Receptores de Hialuronatos/imunologia , Ácido Hialurônico/uso terapêutico , Integrinas/imunologia , Inoculação de Neoplasia , Oligopeptídeos/uso terapêutico , Pneumoperitônio Artificial/efeitos adversos , Animais , Anticorpos Monoclonais/administração & dosagem , Anticorpos Monoclonais/imunologia , Especificidade de Anticorpos , Dióxido de Carbono/administração & dosagem , Carcinoma/patologia , Moléculas de Adesão Celular/antagonistas & inibidores , Linhagem Celular Tumoral/transplante , Avaliação Pré-Clínica de Medicamentos , Sinergismo Farmacológico , Feminino , Humanos , Ácido Hialurônico/administração & dosagem , Injeções Intraperitoneais , Camundongos , Camundongos Endogâmicos BALB C , Transplante de Neoplasias , Oligopeptídeos/administração & dosagem , Neoplasias Gástricas/patologia , Transplante Heterólogo , Carga Tumoral/efeitos dos fármacos
9.
Diabetologia ; 47(12): 2145-51, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15662555

RESUMO

AIMS/HYPOTHESIS: Several studies have reported that coffee has a protective effect against the development of type 2 diabetes. However, few of these studies used the standard glucose tolerance test to diagnose type 2 diabetes. The aim of this study was to investigate the relationship between coffee and green tea consumption and glucose tolerance status as determined using a 75-g OGTT. METHODS: We performed a cross-sectional study of 3224 male officials of the self-defence forces. Glucose tolerance status was determined in accordance with the 1998 World Health Organization criteria, and average intakes of coffee and green tea over the previous year were assessed by a self-administered questionnaire. The figures obtained were adjusted for BMI, physical activity and other factors. RESULTS: A total of 1130 men were identified as having glucose intolerance (IFG, IGT or type 2 diabetes). Compared with those who did not consume coffee on a daily basis, fasting and 2-h post-load plasma glucose levels were 1.5% and 4.3% lower in those who drank 5 cups of coffee or more per day respectively. The adjusted odds ratios of glucose intolerance for categories of <1, 1-2, 3-4 and >/=5 cups of coffee per day were 1.0 (referent), 0.8 (95% CI 0.6-1.0), 0.7 (95% CI 0.6-0.9) and 0.7 (95% CI 0.5-0.9) respectively (p=0.0001 for trend). No clear association was observed between green tea drinking and glucose tolerance status. CONCLUSIONS/INTERPRETATION: Coffee consumption may inhibit postprandial hyperglycaemia and thereby protect against the development of type 2 diabetes mellitus.


Assuntos
Glicemia/metabolismo , Café , Diabetes Mellitus Tipo 2/epidemiologia , Chá , Consumo de Bebidas Alcoólicas , Estudos Transversais , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/diagnóstico , Teste de Tolerância a Glucose , Humanos , Japão/epidemiologia , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Fumar
10.
Antimicrob Agents Chemother ; 45(11): 3250-2, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11600393

RESUMO

The in vivo activity of telithromycin against erythromycin A- and penicillin G-resistant Streptococcus pneumoniae was superior to that of azithromycin, clarithromycin, cefdinir, and levofloxacin. In respiratory tract infections caused by erythromycin A-susceptible S. pneumoniae or Haemophilus influenzae in mice, telithromycin was more effective than clarithromycin and comparable to azithromycin.


Assuntos
Antibacterianos/uso terapêutico , Infecções por Haemophilus/tratamento farmacológico , Haemophilus influenzae , Cetolídeos , Macrolídeos , Infecções Pneumocócicas/tratamento farmacológico , Streptococcus pneumoniae , Animais , Antibacterianos/farmacologia , Resistência a Medicamentos , Eritromicina/farmacologia , Infecções por Haemophilus/microbiologia , Meia-Vida , Masculino , Camundongos , Camundongos Endogâmicos CBA , Camundongos Endogâmicos ICR , Testes de Sensibilidade Microbiana , Infecções Pneumocócicas/microbiologia , Infecções Respiratórias/tratamento farmacológico , Infecções Respiratórias/microbiologia
11.
Jpn J Pharmacol ; 87(1): 67-73, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11676200

RESUMO

The influence of the phytoestrogen, isoflavones, on vasodilating responses of the thoracic aorta precontracted with norepinephrine, together with the stimulatory effect on uterine weight (uterotrophic effect), was investigated in ovariectomized rats. In comparison with intact rats, acetylcholine (ACh)-induced vasodilation showed a tendency to be decreased by ovariectomy. On the other hand, isoprenaline (ISO)-induced vasodilation was significantly increased by ovariectomy. Estrogen replacement (17beta-estradiol dipropionate, 300 microg/kg per week, for 1 month) completely restored the impaired ACh- and ISO-induced vasodilation caused by ovariectomy. Dietary isoflavone aglycones (containing 52% genistein, 42% daidzein and 6% glycitein) of 157 mg/kg per day (not 67 mg/kg per day) for 1 month, in addition to the effects of estrogen replacement, completely restored the impaired vasodilation caused by ovariectomy. However, the uterotrophic effect of dietary isoflavones of 157 mg/kg per day was incomplete as compared with that by estrogen replacement. These results indicate that phytoestrogen, isoflavones, certainly possess estrogenic actions on the vasodilating responses caused by ACh and ISO, as well as a weaker uterotrophic effect.


Assuntos
Acetilcolina/farmacologia , Aorta/efeitos dos fármacos , Estrogênios não Esteroides/farmacologia , Isoproterenol/farmacologia , Vasodilatação/efeitos dos fármacos , Vasodilatadores/farmacologia , Animais , Aorta/fisiologia , Dieta , Relação Dose-Resposta a Droga , Estradiol/farmacologia , Terapia de Reposição de Estrogênios , Feminino , Técnicas In Vitro , Isoflavonas/farmacologia , Modelos Animais , Ovariectomia , Fitoestrógenos , Preparações de Plantas , Ratos , Ratos Wistar
12.
Metabolism ; 50(10): 1213-9, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11586496

RESUMO

We previously reported that the human melanoma cell line, SEKI, induces severe weight loss in nude mice. In the present study, we examined the expression of weight-regulating neuropeptide mRNAs in the hypothalamus of this cancer cachectic model by using a sensitive quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) method and in situ hybridization. mRNA levels of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH) in the whole hypothalamus were elevated significantly in the SEKI mice as compared with control mice. In situ hybridization showed that NPY and CRH mRNA were upregulated in the arcuate nucleus and the paraventricular nucleus, respectively. There were no significant differences in melanin-concentrating hormone (MCH), orexin (OX), and cholecystokinin mRNA levels between the SEKI and control mice. These results suggest that the NPYergic system is functioning in the rodent model of cancer cachexia; however, the role of the CRHergic system in energy homeostasis remains to be elucidated. This is the first report of the hypothalamic neuropeptide response to cachexia-inducing human cells.


Assuntos
Regulação do Apetite , Caquexia/etiologia , Hormônio Liberador da Corticotropina/metabolismo , Hipotálamo/metabolismo , Neoplasias/complicações , Neuropeptídeo Y/metabolismo , Animais , Núcleo Arqueado do Hipotálamo/metabolismo , Peso Corporal , Hormônio Liberador da Corticotropina/análise , Primers do DNA , Feminino , Histocitoquímica , Humanos , Hibridização In Situ , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Neoplasias/metabolismo , Neoplasias/patologia , Neuropeptídeo Y/análise , RNA Mensageiro/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fatores de Tempo
13.
J Antimicrob Chemother ; 48(3): 425-30, 2001 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11533011

RESUMO

Azithromycin is an azalide with potent activity against Haemophilus influenzae including ampicillin-resistant strains. We evaluated the efficacy of azithromycin, clarithromycin and three beta -lactams when used for 1 day only and for 3 days for the treatment of a murine model of bronchopneumonia, using three strains of H. influenzae, two of which were ampicillin resistant. MICs of azithromycin (1-2 mg/L) and clarithromycin (4-8 mg/L) were similar for the three strains. The MICs of cefdinir and cefcapene for beta-lactamase-negative ampicillin-resistant (BLNAR) H. influenzae were 32 times higher than those for beta-lactamase-positive ampicillin-resistant and ampicillin-susceptible strains. The viable counts in the infected tissues of azithromycin-treated mice with bronchopneumonia caused by the susceptible strain TUM8, beta-lactamase-positive strain TUH36 and BLNAR strain TUH267 were less than the counts obtained with the other antibiotics used, irrespective of MIC. At a dose of 50 mg/kg, the area under the concentration curve and the half-life of azithromycin in the lungs were respectively three times higher and six times longer than those of clarithromycin. Our results indicate that azithromycin may be useful for both ampicillin-susceptible and ampicillin-resistant bronchopneumonial infections caused by H. influenzae.


Assuntos
Antibacterianos/uso terapêutico , Broncopneumonia/tratamento farmacológico , Infecções por Haemophilus/tratamento farmacológico , Haemophilus influenzae , Animais , Antibacterianos/administração & dosagem , Azitromicina/administração & dosagem , Azitromicina/uso terapêutico , Broncopneumonia/microbiologia , Claritromicina/administração & dosagem , Claritromicina/uso terapêutico , Modelos Animais de Doenças , Haemophilus influenzae/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos ICR , Testes de Sensibilidade Microbiana , Resultado do Tratamento , beta-Lactamas/administração & dosagem , beta-Lactamas/uso terapêutico
14.
Intern Med ; 40(8): 764-8, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11518120

RESUMO

A 53-year-old Japanese man with recurrent interstitial pneumonia was referred to us. The patient had taken a traditional herb medicine, otsu-ji-to, before the onset of pneumonia. A provocation test for each herbal ingredient contained in otsu-ji-to revealed that the pneumonitis had been induced by ou-gon (scullcap). Lymphocytosis with the CD8+ T-cell subset predominance was found in the bronchoalveolar lavage fluid and lymphocytic alveolitis was noted in the transbronchial lung biopsy specimen after the provocation test. Ou-gon, or scullcap, should be included in the list of drugs with definite causal association with pneumonitis.


Assuntos
Medicamentos de Ervas Chinesas/efeitos adversos , Doenças Pulmonares Intersticiais/induzido quimicamente , Doenças Pulmonares Intersticiais/diagnóstico , Medicina Kampo , Biópsia , Linfócitos T CD8-Positivos , Humanos , Pulmão/patologia , Doenças Pulmonares Intersticiais/diagnóstico por imagem , Doenças Pulmonares Intersticiais/patologia , Masculino , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X
15.
Am J Chin Med ; 29(2): 367-75, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11527078

RESUMO

Sheng-mei-san (SMS), a traditional Chinese formulation comprising Radix Ginseng, Radix Ophiopogonis and Fructus Schisandrae, has long been used for more than 700 years for patients with coronary heart disease. We attempted to clarify 1) whether SMS reduces myocardial infarct size, and 2) whether the infarct size-reducing effect of SMS is related to activation of protein kinase C and the opening of the mitochondrial KATP channels in Japanese white rabbits without collateral circulation. The results indicate that three days treatment but not acute treatment with SMS reduces myocardial infarct size through activation of protein kinase C and opening of the mitochondrial KATP channels.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Proteínas de Membrana/efeitos dos fármacos , Infarto do Miocárdio/tratamento farmacológico , Infarto do Miocárdio/metabolismo , Proteína Quinase C/metabolismo , Análise de Variância , Animais , Combinação de Medicamentos , Hemodinâmica/efeitos dos fármacos , Masculino , Infarto do Miocárdio/enzimologia , Infarto do Miocárdio/patologia , Canais de Potássio , Coelhos
16.
Surg Today ; 31(6): 521-6, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11428606

RESUMO

A 41-year-old man with Cronkhite-Canada syndrome presented with multiple juvenile polyps with hyperplastic and adenomatous changes throughout his stomach and entire colorectum. Dysgeusia was recognized and the degree of hypoproteinemia was remarkable. A barium enema study and colonofiberscopy also revealed an advanced cancer in the rectum. Chronic hepatitis B and membranous glomerulonephritis were also present. It was difficult to design a conservative protocol using steroids for the treatment of protein-loosing enteropathy because the patient was a hepatitis B virus carrier. As a result, a subtotal colectomy while preserving the cecum with cecorectal anastomosis was performed. Pathologically, the ulcerated rectal tumor was a moderately differentiated adenocarcinoma with invasion into the muscularis propria. Most polyps showed cystically dilated glands without dysplasia or edematous stroma with inflammatory cell infiltration. A few polyps were juvenile-type polyps with adenoma components. Although no remarkable improvement was observed in the hypoproteinemia postoperatively, an alpha1-antitrypsin clearance test showed a significant decrease in protein loss from the gastrointestinal tract, which was only about one third of the loss seen preoperatively. These findings lead us to conclude that when improvement using conservative treatment can be neither obtained nor is expected, then the use of surgery should be considered when treating patients with Cronkhite-Canada syndrome.


Assuntos
Adenocarcinoma/complicações , Colectomia , Pólipos Intestinais/complicações , Pólipos Intestinais/cirurgia , Neoplasias Retais/complicações , Adulto , Sulfato de Bário , Colectomia/métodos , Enema , Humanos , Masculino , Enteropatias Perdedoras de Proteínas/etiologia
17.
Plant Cell Physiol ; 42(1): 20-7, 2001 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-11158440

RESUMO

To investigate the roles of peroxisomal membrane proteins in the reversible conversion of glyoxysomes to leaf peroxisomes, we characterized several membrane proteins of glyoxysomes. One of them was identified as an ascorbate peroxidase (pAPX) that is localized on glyoxysomal membranes. Its cDNA was isolated by immunoscreening. The deduced amino acid sequence encoded by the cDNA insert does not have a peroxisomal targeting signal (PTS), suggesting that pAPX is imported by one or more PTS-independent pathways. Subcellular fractionation of 3- and 5-d-old cotyledons of pumpkin revealed that pAPX was localized not only in the glyoxysomal fraction, but also in the ER fraction. A magnesium shift experiment showed that the density of pAPX in the ER fraction did not increase in the presence of Mg(2+), indicating that pAPX is not localized in the rough ER. Immunocytochemical analysis using a transgenic Arabidopsis which expressed pumpkin pAPX showed that pAPX was localized on peroxisomal membranes, and also on a unknown membranous structure in green cotyledons. The overall results suggested that pAPX is transported to glyoxysomal membranes via this unknown membranous structure.


Assuntos
Cucurbitaceae/enzimologia , Peroxidases/análise , Peroxissomos/enzimologia , Sequência de Aminoácidos , Arabidopsis/enzimologia , Ascorbato Peroxidases , Membrana Celular/enzimologia , Cotilédone/enzimologia , Cucurbitaceae/genética , Cucurbitaceae/crescimento & desenvolvimento , DNA Complementar/análise , Retículo Endoplasmático Rugoso/enzimologia , Glioxissomos/enzimologia , Immunoblotting , Técnicas In Vitro , Proteínas de Membrana/análise , Microscopia Imunoeletrônica , Dados de Sequência Molecular , Peroxidases/química , Peroxidases/genética , Peroxidases/metabolismo , Plantas Geneticamente Modificadas , Transporte Proteico , Receptores de Superfície Celular/fisiologia
19.
Nutr Cancer ; 41(1-2): 111-8, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-12094613

RESUMO

We selected three human cancer cell lines [human melanoma (SEKI), human melanoma (G361), and human neuroepithelioma (NAGAI)] that have an ability to develop cancer cachexia syndrome with and without accompanying anorexia and examined the hypothalamic levels of mRNAs for neuropeptide Y (NPY), melanin-concentrating hormone, and orexin. The body weight of sham-operated mice continued to increase, while mice of all tumor-bearing groups lost weight. Competitive reverse transcription-polymerase chain reaction analysis showed that, regardless of feeding status, NPY mRNA levels were elevated in all tumor-bearing mice compared with sham-operated mice, although to a lesser degree than weight-matched pair-weight mice. Melanin-concentrating hormone and orexin mRNA in the hypothalamus followed the same pattern as NPY, although most of the differences did not reach statistical significance. These results support the notion that the response of NPY mRNA to a negative energy balance is less sensitive in these rodent models of cancer cachexia.


Assuntos
Caquexia/metabolismo , Metabolismo Energético , Expressão Gênica , Hipotálamo/metabolismo , Interleucina-6 , Peptídeos e Proteínas de Sinalização Intracelular , Neoplasias Experimentais/complicações , Neuropeptídeo Y/genética , Animais , Caquexia/etiologia , Proteínas de Transporte/genética , Ingestão de Alimentos , Feminino , Inibidores do Crescimento/sangue , Inibidores do Crescimento/genética , Humanos , Hormônios Hipotalâmicos/genética , Hipotálamo/química , Fator Inibidor de Leucemia , Linfocinas/sangue , Linfocinas/genética , Melaninas/genética , Melanoma Experimental/complicações , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Transplante de Neoplasias , Tumores Neuroectodérmicos Primitivos Periféricos/complicações , Neuropeptídeos/genética , Orexinas , Tamanho do Órgão , Hormônios Hipofisários/genética , RNA Mensageiro/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células Tumorais Cultivadas , Redução de Peso
20.
J Antimicrob Chemother ; 46(4): 629-32, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11020264

RESUMO

The MIC90 of glycylcycline (< or =0.06 mg/L) against 55 strains of Streptococcus pneumoniae was 100-fold lower than that of minocycline or tetracycline. In a mouse model of penicillin-resistant S. pneumoniae (PRSP) pneumonia, glycylcycline (10 mg/kg) decreased bacterial counts in the lungs from 10(6) cfu to <10(2) cfu, whereas no apparent reduction of bacterial numbers was observed with minocycline or penicillin G. Pharmacokinetic studies showed that the half-life and area under the curve of glycylcycline were superior to those of minocycline and penicillin G in the lungs. These results show a preferential distribution of glycylcycline in the lungs and potent in vivo bactericidal activity in PRSP pneumonia.


Assuntos
Antibacterianos/uso terapêutico , Modelos Animais de Doenças , Pneumonia Pneumocócica/tratamento farmacológico , Streptococcus pneumoniae/efeitos dos fármacos , Animais , Antibacterianos/sangue , Antibacterianos/farmacocinética , Feminino , Pulmão/metabolismo , Camundongos , Camundongos Endogâmicos CBA , Testes de Sensibilidade Microbiana/métodos , Minociclina/sangue , Minociclina/farmacocinética , Minociclina/uso terapêutico , Penicilina G/sangue , Penicilina G/farmacocinética , Penicilina G/uso terapêutico , Penicilinas/sangue , Penicilinas/farmacocinética , Penicilinas/uso terapêutico , Pneumonia Pneumocócica/metabolismo , Tetraciclina/sangue , Tetraciclina/farmacocinética , Tetraciclina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA